Sangamo Therapeutics
SGMO
#10505
Rank
โ‚น1.95 B
Marketcap
โ‚น4.72
Share price
-28.57%
Change (1 day)
-89.23%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น7.78 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are โ‚น7.78 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น6.76 B-1.41%
2023-12-31โ‚น6.86 B-69%
2022-12-31โ‚น22.13 B-14.17%
2021-12-31โ‚น25.79 B-20.05%
2020-12-31โ‚น32.26 B120.95%
2019-12-31โ‚น14.60 B-6.41%
2018-12-31โ‚น15.60 B147.22%
2017-12-31โ‚น6.31 B328.06%
2016-12-31โ‚น1.47 B-10.53%
2015-12-31โ‚น1.64 B-28.92%
2014-12-31โ‚น2.31 B96.18%
2013-12-31โ‚น1.18 B22.37%
2012-12-31โ‚น0.96 B153.4%
2011-12-31โ‚น0.38 B19.92%
2010-12-31โ‚น0.31 B-56.26%
2009-12-31โ‚น0.72 B21.36%
2008-12-31โ‚น0.59 B29.5%
2007-12-31โ‚น0.46 B47.51%
2006-12-31โ‚น0.31 B-37.65%
2005-12-31โ‚น0.50 B394.27%
2004-12-31โ‚น0.10 B42.16%
2003-12-31โ‚น71.52 M-24.71%
2002-12-31โ‚น94.99 M-26.21%
2001-12-31โ‚น0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น11.307 T 145,176.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.869 T 101,009.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.023 T 13,044.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น4.063 T 52,105.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.102 T 39,762.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น7.816 T 100,329.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น382.95 B 4,820.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น224.71 B 2,787.03%๐Ÿ‡บ๐Ÿ‡ธ USA